 | Up a level |
2022
Jaeger, A., Hampl, M., Zu Eulenburg, C., Prieske, K., Hambrecht, J., Fuerst, S., Klapdor, R., Heublein, S., Gass, P., Rohner, A., Canzler, U., Becker, S., Bommert, M., Bauerschlag, D., Denecke, A., Hanker, L., Runnebaum, I, Forner, D. M., Schochter, F., Klar, M., Schwab, R., Koepke, M., Kalder, M., Hantschmann, P., Ratiu, D., Denschlag, D., Schroeder, W., Tuschy, B., Baumann, K., Mustea, A., Soergel, P., Bronger, H., Bauerschmitz, G., Kosse, J., Koch, M. C., Ignatov, A., Sehouli, J., Dannecker, C., Mahner, S. and Woelber, L. (2022). Risk of pelvic metastasis and significance of pelvic lymphadenectomy in patients with node-positive vulvar cancer - results of the AGO-VOP.2/QS vulva study. Geburtshilfe Frauenheilkd., 82 (10). S. E97 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Weichert, W., Bartels, S., Braicu, I., Christinat, Y., Demes, M., Endris, V., Herold, S., Heukamp, L. C., Hummel, M., Lehmann, U., Merkelbach-Bruse, S., Pfarr, N., Rad, R., Sehouli, J., Siemanowski, J., Stenzinger, A., von Schwarzenberg, K., Vollbrecht, C., Wild, P. J. and Zocholl, D. (2022). High concordance of different molecular assays in the determination of HRD associated GIS in high grade epithelial ovarian cancer. Ann. Oncol., 33 (7). S. S808 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041
2021
Baessler, K., Windemut, S., Chiantera, V, Koehler, C. and Sehouli, J. (2021). Sexual, bladder and bowel function following different minimally invasive techniques of radical hysterectomy in patients with early-stage cervical cancer. Clin. Transl. Oncol., 23 (11). S. 2335 - 2344. CHAM: SPRINGER INT PUBL AG. ISSN 1699-3055
Weichert, W., Bartels, S., Baretton, G., Braicu, E. I., Demes, M. C., Endris, V., Herold, S., Heukamp, L., Hummel, M., Lehmann, U., Merkelbach-Bruse, S., Pfarr, N., Rad, R., Sehouli, J., Siemanowski, J., Stenzinger, A., von Schwarzenberg, K., Vollbrecht, C., Wild, P. and Zocholl, D. (2021). Concordance between multiple HRD assays is substantial in high-grade ovarian cancer. Ann. Oncol., 32. S. S747 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
2020
Jueckstock, J., Fuerst, S., Bommert, M., Harter, P., Prieske, K., Eulenburg, C., Hilpert, F., deGregorio, N., Iborra, S., Sehouli, J., Ignatov, A., Hillemanns, P., Jaeger, A., Strauss, H-G, Baumann, K., Thiel, F., Mustea, A., Meier, W., Wimberger, P., Hanker, L., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Woelber, L. and Mahner, S. (2020). Importance of pelvic Lymphonodectomy in Squamous Cell Carcinoma of the Vulva (VSCC) Subgroup Analysis of the AGO-CaRE-1 Study. Geburtshilfe Frauenheilkd., 80 (7). S. 740 - 741. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Prieske, K., Woelber, L., Muallem, M. Z., Eulenburg, C., Jueckstock, J., Hilpert, F., de Gregorio, N., Iborra, S., Ignatov, A., Hillemanns, P., Fuerst, S. T., Strauss, H. G., Baumann, K., Thiel, F., Mustea, A., Meier, W., Harter, P., Wimberger, P., Hanker, L., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Sehouli, J. and Mahner, S. (2020). The influence of age on treatment and prognosis of patients with squamous cell vulvar cancer (VSCC)- a subset analysis of the AGO-CaRE-1 study. Geburtshilfe Frauenheilkd., 80 (10). S. E201 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
2018
Belau, A., du Bois, A., Sehouli, J., Reuss, A., Lampe, B., Meier, W., Stuth, R., Forner, D. M., Elling, D., Denschlag, D., Pfisterer, J., Gnauert, K., Armin, B., von Koch, F. E., Valter, M., Mahner, S., Runnebaum, I. B., Schmalfeldt, B., Wagner, U. and Harter, P. (2018). lion-lymphadenectomy in ovarian neoplasms.a prospective randomized ago study group led gynecologyc cancer intergroup trial. Oncol. Res. Treat., 41. S. 13 - 14. BASEL: KARGER. ISSN 2296-5262
2016
Sehouli, J., Mahner, S., Neunhoeffer, T., Harter, P., de Gregorio, N., Fridrich, C., Markmann, S., Richter, R., Potenberg, J., Lorenz, R., Schmidt, M., Doering, G., Belau, A., Lueck, H. J., Chekerov, R., du Bois, A. and Hilpert, F. (2016). Topotecan (T) +/- Sorafenib (S) for platinum-resistant ovarian cancer (PROC): results of doubleblind placebo-controlled randomized NOGGO - AGO intergroup trial. Int. J. Gynecol. Cancer, 26. S. 2 - 4. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1525-1438
2014
Hillemanns, P., Woelber, L., Jueckstock, J., Neuser, P., Hilpert, F., Harter, P., De Gregorio, N., Hasenburg, A., Sehouli, J., Habermann, A., Fuerst, S. T., Strauss, H. -G., Baumann, K., Thiel, F., Mustea, A., Meier, W., Du Bois, A., Wimberger, P., Hanker, L., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Richter, B., Petersen, C. and Mahner, S. (2014). AGO Vulva CaRE-1 multicenter study - adjuvant radio(chemo)therapy in vulvar cancer. Oncol. Res. Treat., 37. S. 70 - 71. BASEL: KARGER. ISSN 2296-5262
Woelber, L., Jueckstock, J., Hilpert, F., Neuser, P., Harter, P., De Gregorio, N., Iborra, S., Sehouli, J., Habermann, A., Hillemanns, P., Fuerst, S., Strauss, H. -G., Baumann, K. H., Thiel, F., Mustea, A., Meier, W., Du Bois, A., Wimberger, P., Hanker, L. C., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Richter, B., Griebel, L. -F. and Mahner, S. (2014). Outcome parameters in node-negative vulvar cancer - subset analysis of the AGO CaRE-1 study. Oncol. Res. Treat., 37. S. 72 - 74. BASEL: KARGER. ISSN 2296-5262